Drugs / standard intravenous immunoglobulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01659684 | Oct 2010 → Nov 2014 | fetal cytomegalovirus syndrome | Fondazione Onlus Camillo De Lellis | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | standard intravenous immunoglobulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01659684 ↗ |
| Known as | IVIG | “Human standard intravenous immunoglobulin (IVIG), 0.5 g/Kg of body weight, monthly after confirmation of primary gestational CMV infection” NCT01659684 ↗ |
| Modality | Protein / enzyme biologic | “Human standard intravenous immunoglobulin (IVIG)” NCT01659684 ↗ |
| Route | Intravenous | “Human standard intravenous immunoglobulin (IVIG)” NCT01659684 ↗ |